XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common stock
Treasury stock
Additional paid-in-capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Common stock, beginning balance (in shares) at Dec. 31, 2021   57,695,000        
Beginning balance at Dec. 31, 2021 $ (125,995) $ 577 $ (4,764) $ 615,032 $ (812) $ (736,028)
Treasury stock, beginning balance (in shares) at Dec. 31, 2021     487,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 123,441     123,441    
Issuance of common stock under employee stock purchase plan (in shares)   218,000        
Issuance of common stock under employee stock purchase plan 11,943 $ 2   11,941    
Vesting of restricted stock units (in shares)   1,482,000        
Vesting of restricted stock units 0 $ 15   (15)    
Shares withheld for employee taxes (in shares)   (105,000)        
Shares withheld for employee taxes (7,462) $ (1)   (7,461)    
Issuance of common stock upon exercise of stock options (in shares)   480,000        
Issuance of common stock upon exercise of stock options 3,318 $ 5   3,313    
Issuance of common stock in connection with conversion of convertible senior notes (3)     (3)    
Issuance of common stock related to acquisition (in shares)   33,000        
Repurchase of common stock issued in relation to acquisition (in shares)   (83,000)        
Repurchase of common stock issued in relation to acquisition 0 $ (1)   1    
Other comprehensive income (loss) (599)       (599)  
Net income (loss) (124,717)         (124,717)
Common stock, ending balance (in shares) at Dec. 31, 2022   59,720,000        
Ending balance at Dec. 31, 2022 (120,074) $ 597 $ (4,764) 746,249 (1,411) (860,745)
Treasury stock, ending balance (in shares) at Dec. 31, 2022     487,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 110,809     110,809    
Issuance of common stock under employee stock purchase plan (in shares)   330,000        
Issuance of common stock under employee stock purchase plan 11,323 $ 3   11,320    
Vesting of restricted stock units (in shares)   1,454,000        
Vesting of restricted stock units 0 $ 15   (15)    
Shares withheld for employee taxes (in shares)   (113,000)        
Shares withheld for employee taxes (5,570) $ (1)   (5,569)    
Issuance of common stock upon exercise of stock options (in shares)   216,000        
Issuance of common stock upon exercise of stock options 3,053 $ 2   3,051    
Issuance of common stock related to acquisition (in shares)   107,000        
Issuance of common stock related to acquisition 0 $ 1   (1)    
Repurchase of common stock issued in relation to acquisition (in shares)     83,000      
Repurchase of common stock issued in relation to acquisition 0   $ (1) 1    
Purchase of capped called related to convertible senior notes (36,570)     (36,570)    
Reclassification of equity to derivative assets related to capped calls 33,029     33,029    
Repurchase and inducement of convertible senior notes 35,881     35,881    
Other comprehensive income (loss) 2,755       2,755  
Net income (loss) $ (152,815)         (152,815)
Common stock, ending balance (in shares) at Dec. 31, 2023 61,714,051 61,714,000        
Ending balance at Dec. 31, 2023 $ (118,179) $ 617 $ (4,765) 898,185 1,344 (1,013,560)
Treasury stock, ending balance (in shares) at Dec. 31, 2023 569,579   570,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense $ 105,179     105,179    
Issuance of common stock under employee stock purchase plan (in shares)   292,000        
Issuance of common stock under employee stock purchase plan 9,246 $ 3   9,243    
Vesting of restricted stock units (in shares)   1,435,000        
Vesting of restricted stock units 0 $ 15   (15)    
Shares withheld for employee taxes (in shares)   (104,000)        
Shares withheld for employee taxes (4,730) $ (1)   (4,729)    
Vesting of equity awards previously classified as liabilities (in shares)   27,000        
Vesting of equity awards previously classified as liabilities 1,652     1,652    
Issuance of common stock upon exercise of stock options (in shares)   133,000        
Issuance of common stock upon exercise of stock options 1,566 $ 1   1,565    
Repurchase of common stock issued in relation to acquisition (in shares)     1,000      
Other comprehensive income (loss) (2,549)       (2,549)  
Net income (loss) $ 25,526         25,526
Common stock, ending balance (in shares) at Dec. 31, 2024 63,496,965 63,497,000        
Ending balance at Dec. 31, 2024 $ 17,711 $ 635 $ (4,765) $ 1,011,080 $ (1,205) $ (988,034)
Treasury stock, ending balance (in shares) at Dec. 31, 2024 570,255   571,000